Back to Directory

Renee Browning

Email

browningr@niaid.nih.gov

Phone

240-292-4781

Institution

Division of Aids

Address

DAIDS/NIAID/NIH
Maternal Adolescent and Pediatric Research Branch
Prevention Sciences Program
5601 Fishers Lane, 8B29
Rockville, MD 20852
USA

Request an Update

Affiliated Studies

IMPAACT 2041: Phase I/II Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir in People with Hepatitis C During Pregnancy

DAIDS Number

Research Area

Complications & Comorbidities

Study Status

P1108: A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Bedaquiline (BDQ) Given in Combination with an Individualized Rifampin-Resistant Tuberculosis (RR-TB) Therapy in Infants, Children and Adolescents with RR-TB Disease, Living with or without HIV

DAIDS Number

Research Area

IMPAACT 2034: Phase I Study of the Pharmacokinetics, Safety, and Acceptability of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children with Rifampicin-Resistant Tuberculosis

DAIDS Number

Research Area

Study Status

Open to Accrual

IMPAACT 2040: Phase I/II Pharmacokinetics and safety of long-acting injectable Cabotegravir and Rilpivirine in people with virally suppressed HIV-1 during pregnancy and postpartum

DAIDS Number

Research Area

Study Status

P1026S: PK in Pregnancy

DAIDS Number

Research Area

Study Status

Closed to Follow Up

Show All